Treatment with Gemfibrozil, a potent TFEB-inducing autophagic drug, protected from CS-induced TFEB/autophagy-impairment and COPD-emphysema pathogenesis [213]. The gene discussed is TFEB; the disease is chronic obstructive pulmonary disease.